AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇨🇮

TRASTUZUMAB in Côte d'Ivoire

4 products registered with AIRP 4 active

Brand / ProductReg. No.HolderStatusExpires
KADCYLA 100MG POUDRE POUR SOLUTION A DILUER POUR PERFUSION BOITE DE 1MD/3O0822-0086F. HOFFMANN-LA ROCHE LTDactive4 Jun 2028
KADCYLA 160MG POUDRE POUR SOLUTION A DILUER POUR PERFUSION BOITE DE 1MD/3O0822-0085F. HOFFMANN-LA ROCHE LTDactive6 Apr 2028
HERCEPTIN 150MG/5ML POUR POUR SOLUTION A DILUER POUR PERFUSION FLACON DE 15MLE-2002-086F. HOFFMANN-LA ROCHE LTDactive30 Oct 2027
HERCEPTIN 600MG/5ML POUDRE POUR SOLUTION A DILUER POUR PERFUSION FLACON DE 15MLMD/201525/0684F. HOFFMANN-LA ROCHE LTDactive

TRASTUZUMABAIRP Registration Details

AIRP (Côte d'Ivoire) has 4 registered products containing TRASTUZUMAB, of which 4 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.

Track TRASTUZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Trastuzumab — Côte d'Ivoire (AIRP) | AfricaRegulatory